Quality Management Systems and Sustainable Performance in Medical Device Companies
Sustainability · 19.11.2026 · 18 (22) · 11804
DOI: 10.3390/su182211804 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sustainability, online erschienen am 19.11.2026. Verfasst von Nicoleta-Lăcrămioara Manta und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study evaluated the ISO 13485 standard, an international standard specifying quality management system (QMS) requirements for the medical device (MD) industry, from multiple perspectives, including the reasons for its development, as well as its global applicability, particularly in Europe, the USA, and Canada. However, there is a lack of research regarding the implementation of the standard by leading companies in the MD sector, which limits the understanding of its importance and operational role. To address this gap, a case study methodology was employed, focusing on the top 10 global MD companies, including Abbott, Medtronic, Johnson & Johnson, Siemens Healthineers, Boston Scientific, Philips, GE HealthCare, Zimmer Biomet, Becton Dickinson, and Stryker. The comparative analysis considered company size, product portfolio, financial performance, and certification status in order to assess how ISO 13485:2016 serves as a common quality baseline alongside varying operational profile and sustainability practices. The comparative analysis also included environmental, social and governance (ESG) aspects, assessing these dimensions using a structured qualitative approach. The results indicate that ISO 13485:2016 acts as a fundamental baseline for regulatory compliance and market access for all companies analyzed. The ESG analysis included six dimensions: environmental impact, climate & decarbonization, circular economy, social impact, health equity & access, and governance & supply chain. Companies such as Philips, Medtronic, and Johnson & Johnson demonstrate high disclosure-based ESG maturity, while others are in the early stages of ESG integration, being mainly focused on compliance. Overall, ISO 13485:2016 provides a structured foundation for quality and compliance, while disclosure-based ESG maturity varies depending on corporate strategy.
Zitieren
APA
Manta, N., Severin, I., & Caramihai, M. D. (2026). Quality Management Systems and Sustainable Performance in Medical Device Companies. Sustainability, 18(22), 11804. https://doi.org/10.3390/su182211804
Vancouver
Manta N, Severin I, Caramihai MD. Quality Management Systems and Sustainable Performance in Medical Device Companies. Sustainability. 2026;18(22):11804. doi:10.3390/su182211804
BibTeX
@article{Manta2026,
author = {Manta, Nicoleta-Lăcrămioara and Severin, Irina and Caramihai, Mihai Dan},
title = {Quality Management Systems and Sustainable Performance in Medical Device Companies},
journal = {Sustainability},
year = {2026},
volume = {18},
number = {22},
pages = {11804},
doi = {10.3390/su182211804}
}
EUVIMED